Axim Biotechnologies Inc (AXIM)

[BesaoT35]

The market cap is $12 million. If we actually have sales this year of DED tests to ophthalmologists and optometrists and there is a real need for these tests then the valuation could be too low. Janey thinks this is a scam. I see it more as unfortunate the way the NAB test never got used by the public.

What sort of yearly revenues could we hope for from DED? It is a simple test to do in the clinic but there is some question on whether the FDA would require a certified laboratory to do the tests. This uncertainty needs to be cleared up.